USANA Historical Financial Ratios

USNA Stock  USD 38.53  0.63  1.61%   
USANA Health is promptly reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0, PTB Ratio of 2.58 or Days Sales Outstanding of 3.17 will help investors to properly organize and evaluate USANA Health Sciences financial condition quickly.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About USANA Financial Ratios Analysis

USANA Health SciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate USANA Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on USANA financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across USANA Health history.

USANA Health Financial Ratios Chart

At present, USANA Health's Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 3.17, whereas PTB Ratio is forecasted to decline to 2.58.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing USANA Health Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on USANA Health sales, a figure that is much harder to manipulate than other USANA Health Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Tangible Asset Value

The total value of a company's physical, tangible assets, excluding intangible assets like patents and trademarks.
Most ratios from USANA Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into USANA Health Sciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At present, USANA Health's Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 3.17, whereas PTB Ratio is forecasted to decline to 2.58.
 2016 2022 2023 2024 (projected)
Days Sales Outstanding6.182.642.373.17
PTB Ratio4.612.362.712.58

USANA Health fundamentals Correlations

0.72-0.180.66-0.90.88-0.240.720.930.870.31-0.530.980.50.67-0.570.570.980.67-0.610.99-0.69-0.91-0.010.940.95
0.72-0.260.07-0.420.36-0.051.00.650.350.8-0.890.620.90.21-0.020.010.720.63-0.010.78-0.13-0.470.650.690.71
-0.18-0.26-0.280.14-0.10.92-0.26-0.16-0.220.00.44-0.29-0.490.230.56-0.32-0.38-0.50.44-0.3-0.110.15-0.05-0.37-0.34
0.660.07-0.28-0.880.91-0.560.070.650.94-0.490.110.78-0.110.64-0.840.990.690.18-0.860.63-0.71-0.66-0.70.680.74
-0.9-0.420.14-0.88-0.970.35-0.42-0.92-0.970.090.15-0.93-0.13-0.680.72-0.82-0.88-0.420.76-0.850.740.830.39-0.91-0.87
0.880.36-0.10.91-0.97-0.310.360.820.99-0.15-0.120.930.10.81-0.730.850.860.37-0.780.84-0.84-0.85-0.460.820.88
-0.24-0.050.92-0.560.35-0.31-0.05-0.27-0.430.330.17-0.38-0.20.090.78-0.6-0.42-0.390.68-0.310.080.260.32-0.45-0.38
0.721.0-0.260.07-0.420.36-0.050.650.350.8-0.890.620.90.21-0.020.010.720.63-0.010.78-0.13-0.470.650.690.71
0.930.65-0.160.65-0.920.82-0.270.650.820.23-0.410.90.370.46-0.540.580.90.56-0.570.89-0.52-0.79-0.050.970.85
0.870.35-0.220.94-0.970.99-0.430.350.82-0.19-0.140.940.130.76-0.80.890.870.42-0.840.84-0.82-0.85-0.480.840.89
0.310.80.0-0.490.09-0.150.330.80.23-0.19-0.830.150.82-0.070.39-0.570.280.560.390.370.15-0.180.920.230.19
-0.53-0.890.440.110.15-0.120.17-0.89-0.41-0.14-0.83-0.44-0.99-0.010.020.17-0.58-0.73-0.02-0.63-0.040.37-0.74-0.51-0.53
0.980.62-0.290.78-0.930.93-0.380.620.90.940.15-0.440.430.71-0.70.70.980.64-0.740.97-0.75-0.92-0.160.940.96
0.50.9-0.49-0.11-0.130.1-0.20.90.370.130.82-0.990.430.02-0.02-0.160.570.720.030.610.04-0.340.750.480.53
0.670.210.230.64-0.680.810.090.210.460.76-0.07-0.010.710.02-0.440.560.610.25-0.540.63-0.95-0.76-0.390.450.65
-0.57-0.020.56-0.840.72-0.730.78-0.02-0.54-0.80.390.02-0.7-0.02-0.44-0.81-0.66-0.520.99-0.570.640.710.61-0.65-0.59
0.570.01-0.320.99-0.820.85-0.60.010.580.89-0.570.170.7-0.160.56-0.810.610.08-0.820.54-0.62-0.55-0.730.620.69
0.980.72-0.380.69-0.880.86-0.420.720.90.870.28-0.580.980.570.61-0.660.610.74-0.680.99-0.65-0.89-0.020.960.96
0.670.63-0.50.18-0.420.37-0.390.630.560.420.56-0.730.640.720.25-0.520.080.74-0.510.72-0.39-0.750.30.670.55
-0.61-0.010.44-0.860.76-0.780.68-0.01-0.57-0.840.39-0.02-0.740.03-0.540.99-0.82-0.68-0.51-0.590.730.780.65-0.66-0.6
0.990.78-0.30.63-0.850.84-0.310.780.890.840.37-0.630.970.610.63-0.570.540.990.72-0.59-0.64-0.880.070.940.96
-0.69-0.13-0.11-0.710.74-0.840.08-0.13-0.52-0.820.15-0.04-0.750.04-0.950.64-0.62-0.65-0.390.73-0.640.860.5-0.52-0.63
-0.91-0.470.15-0.660.83-0.850.26-0.47-0.79-0.85-0.180.37-0.92-0.34-0.760.71-0.55-0.89-0.750.78-0.880.860.2-0.82-0.79
-0.010.65-0.05-0.70.39-0.460.320.65-0.05-0.480.92-0.74-0.160.75-0.390.61-0.73-0.020.30.650.070.50.2-0.04-0.06
0.940.69-0.370.68-0.910.82-0.450.690.970.840.23-0.510.940.480.45-0.650.620.960.67-0.660.94-0.52-0.82-0.040.9
0.950.71-0.340.74-0.870.88-0.380.710.850.890.19-0.530.960.530.65-0.590.690.960.55-0.60.96-0.63-0.79-0.060.9
Click cells to compare fundamentals

USANA Health Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.83
Revenue Per Share
45.085
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0809
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.